Association of alcohol or other drug dependence with alleles of the μ opioid receptor gene (OPRM1)

Alcoholism: Clinical and Experimental Research

Volumn 22, Issue 6, 1998, Pages 1359-1362

  Kranzler, Henry R ^a   Gelernter, Joel ^b,c   O'Malley, Stephanie ^c   Hernandez Avila, Carlos A ^a   Kaufman, Daniel ^d  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alcohol Dependence; Drug Dependence; Molecular Genetics; Opioid Receptor; Polymorphism

Indexed keywords

MU OPIATE RECEPTOR;

ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG DEPENDENCE; GENE FREQUENCY; GENE ISOLATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0031659387     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1998.tb03919.x     Document Type: Article

References (38)

1. Yu L: The μ opioid receptor: From molecular cloning to functional studies. Addict Biol 1:19-30, 1996
2. Matthes HWD, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques BP, Kieffer BL: Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature 383:819-823, 1997
3. Sora I, Takahashi N, Funada M, Ujike H, Revay RS, Donovan DM, Miner LL, Uhl GR: Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci USA 94:1544-1549, 1997
4. Chen Y, Mestek A, Liu J, Hurley JA, Yu L: Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol Pharmacol 44:8-12, 1993
5. Wang J-B, Johnson PS, Persico AM, Hawkins AL, Griffin CA, Uhl GR: Human μ, opiate receptor. CDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Letters 338: 217-222, 1994
6. Di Chiara G, Imperato A: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278, 1988
7. 1 opioid receptor mechanism. Science 276:2048-2050, 1997
8. Weiss F, Lorang MT, Bloom FE, Koob GF: Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: Genetic and motivational determinants. J Pharmacol Exp Ther 267:250-258, 1993
9. Koob GF, LeMoal M: Drug abuse: Hedonic homeostatic dysregulation. Science 278:52-58, 1997
10. Spanagel R, Herz A, Shippenberg TS: Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89:2046-2050, 1992
11. De Waele JP, Kiianmaa K, Gianoulakis C: Distribution of the μ and δ opioid binding sites in the brain of the alcohol-preferring AA and alcohol-avoiding ANA lines of rats. J Pharmacol Exp Ther 275:518-527, 1995
12. Aguirre JC, Del Arbol JL, Raya J, Ruiz-Requena ME, Irles JR: Plasma beta-endorphin levels in chronic alcoholics. Alcohol 7:409-412, 1990
13. Genazzani A, Nappi G, Facchinetti F, Mazzella GL, Parrini D, Sinforiani E, Petaraglia F, Savoldi F: Central deficiency of beta-endorphin in alcohol addicts. J Clin Endocrinol Metab 55:583-586, 1981
14. Kemper A, Koalick F, Thiele H, Retzow A, Rathsack R, Nickel B: Cortisol and beta-endorphin response in alcoholics and alcohol abusers following a high naloxone dosage. Drug Alcohol Depend 25:319-326, 1990
15. Gianoulakis C, Beliveau D, Angelogianni P, Meaney M, Thavundayil J, Tawar V, Duams M: Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci 45:1097-1109, 1989
16. Gianoulakis C, Krishnan B, Thavundayil J: Enhanced sensitivity of pituitary β-endorphin to ethanol in subjects at high risk of alcoholism. Arch Gen Psychiatry 53:250-257, 1996
17. Hubbell C, Czirr S, Hunter G, Beaman CM, LeCann NC, Reid LD: Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol 3:39-54, 1986
18. De Witte P: Naloxone reduces alcohol intake in a free-choice procedure event when both drinking bottles contain saccharine sodium or quinine substances. Neuropsychobiology 12:73-77, 1984
19. Altshuler H, Phillips P, Feinhandler D: Alteration of ethanol self-administration by naltrexone. Life Sci 26:679-688, 1980
20. Hyytiä P, Sinclair JD: Responding for oral ethanol after naloxone treatment by alcohol preferring AA rats. Alcohol Clin Exp Res 17:631-636, 1993
21. Volpicelli J, O'Brien C, Alterman A, Hayashida M: Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:867-880, 1992
22. O'Malley S, Jaffe A, Chang G, Schottenfeld R, Meyer R, Rounsaville B: Naltrexone and coping skills therapy for alcohol dependence; a controlled study. Arch Gen Psychiatry 49:894-898, 1992
23. Corrigall W, Coen K: Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology 104:167-170, 1991
24. Mello N, Mendelson M, Luksa B, Lukas S: Buprenorphine and NTX effects on cocaine self-administration by Rhesus monkeys. J Pharmacol Exp Ther 254:926-939, 1990
25. Bilsky E, Montegut M, Delong C, Reid L: Opioidergic modulation of cocaine conditioned place preferences. Life Sci 50:85-90, 1992
26. Houdi A, Bardo M, Van Loon G: Opioid mediation of cocaine-induced hyperactivity and reinforcement. Brain Res 497:195-198, 1989
27. De Vry J, Donselaar I, Van Ree J: Food deprivation and acquisition of intravenous cocaine self-administration in rats: Effect of naltrexone and haloperidol. J Pharmacol Exp Ther 251:735-740, 1989
28. Kosten T, Kleber H, Morgan C: Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci 44:887-892, 1989
29. Berrettini WH, Hoehe MR, Ferraro TN, DeMaria PA, Gottheil E: Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse. Addict Biol 2:303-308, 1997
30. Bergen AW, Kokoszka J, Peterson R, Long JC, Virkkunen M, Linnoila M, Goldman D. μ opioid receptor gene variants: Lack of association with alcohol dependence. Mol Psychiatry 2:490-494, 1997
31. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3-rev. Washington, D.C., American Psychiatric Press, 1987
32. Spitzer RL, Williams JBW, Gibbon M, First MB: The Structured Clinical Interview for DSM-III-R (SCID). I. History, rationale and description. Arch Gen Psychiatry 49:624-629, 1992
33. Blouin AG, Perez EL, Blouin JH: Computerized administration of the diagnostic interview schedule. Psychiatry Res 23:335-344, 1988
34. Terwilliger JD: A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. Am J Hum Genet 56:777-787, 1995
35. Falk CT, Rubinstein P: Haplotype relative risks: An easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 51:227-233, 1987
36. Mansour A, Watson SJ: Anatomical distribution of opioid receptors in mammalians: An overview. Handbook Exp Pharmacol 104:79-105, 1993
37. Goldstein A, Naidu A: Multiple opioid receptors: Ligand selectivity profiles and binding site signatures. Mol Pharmacol 36:265-272, 1989
38. Mayer P, Rochlitz H, Rauch E, Rommelspacher H, Hasse HE, Schmidt S, Hollt V: Association between a delta opioid receptor gene polymorphism and heroin dependence in man. Neuroreport 8:2547-2550, 1997